The California legislature is seeking to ban five additives frequently found in foods. Red Dye No. 3, titanium dioxide, potassium bromate, brominated vegetable oil, and propylparaben, all currently banned in the European Union.
The FDA has been claiming that the ingredients are safe.
The proposed bill AB 418 would prohibit the manufacture, sale, or distribution of any food product in California containing those ingredients.
Assemblymember Jesse Gabriel, one of the bill’s two sponsors, called the ingredients “dangerous and toxic chemicals.
According to the proposed bill, scientific studies have shown significant public health harms, including increased risk of cancer, behavioral issues in children, harm to the reproductive system, and damage to the immune system.
If enacted, California would be the first US state to ban the use of these ingredients.


South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Asian Markets Surge as Japan Election, Fed Rate Cut Bets, and Tech Rally Lift Global Sentiment
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Washington Post Publisher Will Lewis Steps Down After Layoffs
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



